Skip to Content

MainStay PineStone International Eq P FCIHX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 16.76  /  −0.24 %
  • Total Assets 475.8 Mil
  • Adj. Expense Ratio
    0.850%
  • Expense Ratio 0.850%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 5.0 Mil
  • Status Open
  • TTM Yield
  • Turnover 12%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:04 PM GMT+0

Morningstar’s Analysis FCIHX

Will FCIHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin MainStay PineStone International Eq P's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FCIHX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

6.71 27.4 Mil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd ADR

5.72 23.3 Mil
Technology

Nestle SA

5.54 22.6 Mil
Consumer Defensive

London Stock Exchange Group PLC

4.91 20.0 Mil
Financial Services

Lvmh Moet Hennessy Louis Vuitton SE

4.55 18.5 Mil
Consumer Cyclical

InterContinental Hotels Group PLC

4.16 17.0 Mil
Consumer Cyclical

Air Liquide SA

3.97 16.2 Mil
Basic Materials

Essilorluxottica

3.90 15.9 Mil
Healthcare

L'Oreal SA

3.74 15.2 Mil
Consumer Defensive

Keyence Corp

3.60 14.7 Mil
Technology